The telehealth company that looked at the most ignored chapter in medicine - menopause - and decided to treat it seriously.
The menu the system forgot: hormones, creams, and a flat fee. New York, NY.
A woman in her late forties opens a laptop at 11pm. Her body has spent two years doing things no one warned her about - heat that arrives without permission, sleep that leaves without notice, a libido that filed for early retirement. She has been to doctors. She has been told it is stress, or age, or simply the price of being a woman. Tonight she opens Alloy Health instead, answers a few questions, and within days a menopause-trained physician sends back an FDA-approved treatment plan and a box to her door.
That is the whole company, really. Alloy Health is a direct-to-consumer telehealth platform built for one of the largest and most under-served groups in medicine: women in perimenopause and menopause. It runs on a flat $50 annual membership, prescriptions starting around $40 a month, and a refusal to play the insurance game. No clinic waiting rooms. No shrugs. Just clinicians who actually specialize in the thing she is going through.
It sounds modest. It is not. Roughly half the planet will pass through menopause, and for decades the medical establishment treated that fact as a footnote.
"Two 40-something friends on a mission to find real health solutions for everything midlife throws at you - and when they came up short, they built Alloy."
- Alloy's own origin lineHere is the inconvenient part. Menopause is not rare, not niche, and not optional. Every woman who lives long enough arrives there. And yet, for years, the standard care was a coin flip between "let's wait and see" and a prescription written by someone who had read one paragraph about hormones in medical school.
A 2002 study spooked a generation of doctors away from hormone therapy, and the caution outlived the science. The result was a strange silence: millions of women with treatable symptoms, and a system that mostly offered sympathy. Sympathy, it turns out, does not fix a hot flash.
The market noticed the silence too. Hot flashes do not trend on a pitch deck the way teen skincare does. So the women aged out of the brands that once courted them, and nobody built the next thing - which is a polite way of saying the opportunity sat in plain sight for years.
The need was enormous and the stigma was louder. Alloy's entire bet is that you can solve a medical problem and a cultural one at the same time - and that women will pay, plainly and gladly, for care that treats them like adults.
Monica Molenaar entered surgical menopause at 40, after having her ovaries removed following a BRCA diagnosis. She went looking for answers and found a maze. Anne Fulenwider came at it from a different angle - she had run Marie Claire as editor-in-chief, a job that gives you a very good radar for what women are not being told. The two friends compared notes and reached the same blunt conclusion: the care they wanted did not exist, so they would have to build it.
They were not casual about the medicine. They recruited Dr. Sharon Malone, a veteran women's health expert - whom they first encountered on Michelle Obama's podcast - as Chief Medical Advisor, and assembled a board-certified team trained specifically in menopause. The founders' wager was unfashionable for a startup: grow slowly, stay profitable, and earn trust instead of buying it.
"The conversation had completely changed."
- Anne Fulenwider, on how investors received Alloy by the Series AFormer editor-in-chief of Marie Claire. The storyteller who knew exactly what women weren't being told.
Entered surgical menopause at 40. The lived experience that turned a gap into a company.
Decades treating women in their menopausal years. The clinical spine of the operation.
Anne Fulenwider and Monica Molenaar start building the menopause company they couldn't find as patients.
Capital to build a telehealth, prescription and community platform for women over 40.
From HRT and vaginal estrogen to skin, hair, sexual-health, gut and weight care - all FDA-approved, all doctor-led.
Led by Kairos HQ, with PACE Healthcare Capital, Emmeline Ventures and Amboy Street Ventures. Profitable at the time of raise.
Profiled by the Nasdaq Entrepreneurial Center; ~125K-strong community keeps growing.
Most telehealth brands pick a lane and stay in it. Alloy went wide on purpose, because menopause does not respect departments. It hits sleep, skin, mood, libido, hair, weight and bones all at once, so the catalog tracks the actual experience rather than the org chart of a hospital.
The mechanics are unglamorous and that is the point. You fill out an asynchronous intake, a menopause-trained doctor reviews it, and treatment ships to your door. The pricing is printed plainly. No referral, no co-pay surprise, no negotiation with a payer who would rather you went away.
FDA-approved estradiol patches and pills for hot flashes, night sweats, sleep and mood.
Estradiol cream for dryness, painful sex and recurrent UTIs. Yes, it's safe - they'll tell you so loudly.
O-Mazing cream and bundles for libido and intimacy that midlife tends to mute.
Clinical formulas with estriol, peptides, hyaluronic acid and tretinoin for changing skin.
Doctor-prescribed minoxidil for the thinning nobody mentioned would happen.
Synbiotic gut support and personalized weight care for a metabolism that quietly rewrote its rules.
The clearest evidence that the conversation changed is the funding curve. Between the seed and the Series A, the same two founders walked into the same investor rooms and got a very different answer.
"Profitable, slow-and-steady, and unfashionable - which is exactly why it worked."
- The unglamorous strategy behind the Series ABeyond the cap table, the proof is human. A community of roughly 125,000 on Instagram. A medical bench led by Dr. Sharon Malone. Backers including Kairos HQ, PACE Healthcare Capital, Emmeline Ventures and Amboy Street Ventures, who saw a category that was finally allowed to exist out loud.
Alloy's stated mission is plain enough to fit on a label: give women in perimenopause and menopause expert care, trusted information, and the widest range of FDA-approved treatments. The deeper aim is harder and more interesting - to retire the idea that being dismissed is part of the deal.
The company does not bill insurance, and that is a values choice as much as a business one. Transparent pricing means a woman knows what she will pay before she commits, which is a small dignity the rest of healthcare rarely bothers to offer.
Get a real menopause diagnosis and plan without a clinic. Fill prescriptions for hormones, skin, hair and sexual health from doctors who specialize in midlife. Learn from a community that says the quiet parts out loud. And pay one predictable fee instead of guessing.
Return to that woman with the open laptop. A few years ago her only options were a doctor who waved her off or a forum thread written by strangers. Now she has a menopause-trained physician, a treatment with her name on it, and a fee she understood before she paid it. The heat still arrives without permission - but now something arrives to meet it.
That is the change Alloy Health is after, multiplied across a generation of women who were told to wait it out. The bet is that midlife care becomes ordinary - expected, even - rather than a thing you have to fight for at midnight.
Half the world goes through menopause. Alloy decided that was a reason to build a company, not an excuse to stay quiet. The laptop closes. For once, she got an answer.